immunotherapies

Immunai has joined forces with Baylor College of Medicine to bring more targeted and effective cancer therapies to market. Leveraging Immunai’s single-cell technology and artificial intelligence, Baylor and Immunai will analyse natural killer T (NKT) cells and genetically engineer them into immunotherapies that target a variety of cancers, including solid tumours. While some immunotherapies like […]

Researchers are continually looking for processes and technology that give them the edge scientifically or commercially. If you are a biotech scientist interested in reversing or overcoming the state of T-cell exhaustion, this webinar will be beneficial to your work. Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells for improved therapeutics will […]

If you are a biotech scientist interested in reversing or overcoming the state of T-cell exhaustion, this webinar will be of interest. Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells for improved therapeutics will be hosted by DDW and presented by Sartorius. It will examine T cell exhaustion and how it is […]